Clinical trial
Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Study Evaluating the Efficacy and Safety of Early Self-Treatment of Viral Upper Respiratory Tract Infections With Homeopathic Oral Antibodies to the TLR3 FYW Peptide (TAO1)
NCT01651715 is registered in ClinicalTrials.gov with Theranor s.p.r.l as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Study Evaluating the Efficacy and Safety of Early Self-Treatment of Viral Upper Respiratory Tract Infections With Homeopathic Oral Antibodies to the TLR3 FYW Peptide (TAO1)
- Lead sponsor
- Theranor s.p.r.l
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- August 31, 2013
- Enrollment
- 232 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.